Volume 5 Issue 1

Volume 4 Issue 1

Volume 3 Issue 1

Volume 2 Issue 1

Volume 1 Issue 1

Recent Articles

2021-01-12 Short Communication

Hypertensive toxicity of thyrosine kinase inhibitors; Friend or Foe?


Tyrosine kinase inhibitors (TKIs) are widely used in Oncology practice. Hypertension may develop during cancer treatment and TKIs are well known drugs that are associated with drug related hypertensive toxicity. TKI related hypertensive toxicity is not always the indicator of worse clinical outcomes and it may be the sign of treatment efficacy.

Abstract Read Full Article HTML DOI: 10.29328/journal.ach.1001025 Cite this Article